Page last updated: 2024-08-23

lovastatin and Benign Psychomotor Epilepsy, Childhood

lovastatin has been researched along with Benign Psychomotor Epilepsy, Childhood in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Abdanipour, A; Anarkooli, IJ; Ganjkhani, M; Moradi, P1
Chen, IC; Jaw, T; Lee, CY; Liou, HH; Tseng, HC1

Other Studies

2 other study(ies) available for lovastatin and Benign Psychomotor Epilepsy, Childhood

ArticleYear
Neuroprotective effects of lovastatin in the pilocarpine rat model of epilepsy according to the expression of neurotrophic factors.
    Metabolic brain disease, 2019, Volume: 34, Issue:4

    Topics: Animals; Apoptosis; Brain-Derived Neurotrophic Factor; Ciliary Neurotrophic Factor; Disease Models, Animal; Epilepsy, Temporal Lobe; Glial Cell Line-Derived Neurotrophic Factor; Hippocampus; Lovastatin; Male; Nerve Growth Factors; Neurons; Neuroprotective Agents; Neurotrophin 3; Pilocarpine; Rats; Rats, Wistar

2019
Lovastatin modulates glycogen synthase kinase-3β pathway and inhibits mossy fiber sprouting after pilocarpine-induced status epilepticus.
    PloS one, 2012, Volume: 7, Issue:6

    Topics: Animals; Anticholesteremic Agents; Blotting, Western; Dentate Gyrus; Disease Models, Animal; Electrophysiology; Epilepsy, Temporal Lobe; Glycogen Synthase Kinase 3; Glycogen Synthase Kinase 3 beta; Intercellular Signaling Peptides and Proteins; Lovastatin; Male; Mossy Fibers, Hippocampal; Muscarinic Agonists; Nerve Tissue Proteins; Pilocarpine; Rats; Rats, Wistar; Seizures; Status Epilepticus

2012